David Wyld
- Oncology top 2%
- Cancer survivorship and care 21
- Lung Cancer Research Studies 21
- Pancreatic and Hepatic Oncology Research 17
- Genetics top 10%
-
- Childhood Cancer Survivors' Quality of Life 17
-
- Palliative Care and End-of-Life Issues 17
-
- Neuroendocrine Tumor Research Advances 32
-
- Neuroblastoma Research and Treatments 17
-
- Radiopharmaceutical Chemistry and Applications 8
- Co-authors
- Monika JandaVanessa L. BeesleyDavid GoldsteinRachel Ε. NealeHelen GoodenNeil D. MerrettDianne L. O’ConnellKen McFarland
- Journals
- Journal of Clinical Oncology (15 papers)Supportive Care in Cancer (7 papers)Psycho-Oncology (4 papers)
- Partner nations
- AustraliaUnited StatesNew Zealand
In The Last Decade
David Wyld
123 papers receiving 2.0k citations
Peers
Comparison fields: 5 of 128
- Oncology 1.2k
- Genetics 146
- Pediatrics, Perinatology and Child Health 261
- Pulmonary and Respiratory Medicine 423
- Public Health, Environmental and Occupational Health 342
Countries citing papers authored by David Wyld
This map shows the geographic impact of David Wyld's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Wyld with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Wyld more than expected).
Fields of papers citing papers by David Wyld
This network shows the impact of papers produced by David Wyld. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Wyld. The network helps show where David Wyld may publish in the future.
Co-authorship network
The 25 scholars most cited alongside David Wyld, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2023 | 1 | |
| 3 | 2023 | 1 | |
| 4 | 2022 | 2 | |
| 5 | 2021 | 2 | |
| 6 | 2020 | 2 | |
| 7 | 2019 | 3 | |
| 8 | Positron Emission Tomography (PET) predictors of tumor response to Peptide Receptor Radionuclide Therapy (PRRT) in metastatic Neuroendocrine Tumors (NET) | 2018 | 1 |
| 9 | A randomized controlled study comparing treatment of gastro-entero-pancreatic neuroendocrine tumors (GEPNET) with 177Lu-DOTATATE alone and in combination with capecitabine | 2018 | 3 |
| 10 | 2017 | 10 | |
| 11 | 2017 | 6 | |
| 12 | Patient reported outcomes (PROs) in clinical practice: a scoping review of reviews, systematic review and meta-analysis of the research | 2017 | 1 |
| 13 | A Single Centres Experience of Cardiac Metastasis from Neuroendocrine Tumours (NET) | 2016 | 1 |
| 14 | 2016 | 47 | |
| 15 | A prospective 2-year experience of a medical oncology advanced trainee in Queensland | 2016 | 1 |
| 16 | 2015 | 26 | |
| 17 | Time from diagnosis of rectal adenocarcinoma to commencement of long course chemoradiotherapy (Lccrt) for metropolitan versus rural patients referred to a Queensland tertiary referral hospital | 2014 | 1 |
| 18 | Rural Oncology Care Via Teleoncology and Outreach Clinics: Patient and Staff Perspectives and Comparisons | 2014 | 1 |
| 19 | Pulmonary Embolism in Medical Oncology Patients: Symptomatic Versus Incidental | 2012 | 1 |
| 20 | 2011 | 54 |
About David Wyld
David Wyld is a scholar working on Oncology, Neurology, Epidemiology, Public Health, Environmental and Occupational Health and Pediatrics, Perinatology and Child Health, having authored 127 papers that have together received 2.1k indexed citations. Recurring topics across this work include Neuroendocrine Tumor Research Advances (32 papers), Cancer survivorship and care (21 papers), Lung Cancer Research Studies (21 papers), Pancreatic and Hepatic Oncology Research (17 papers), Palliative Care and End-of-Life Issues (17 papers), Neuroblastoma Research and Treatments (17 papers), Childhood Cancer Survivors' Quality of Life (17 papers) and Radiopharmaceutical Chemistry and Applications (8 papers). The work is most often cited by research in Oncology (1.2k citations), Genetics (146 citations), Pediatrics, Perinatology and Child Health (261 citations), Pulmonary and Respiratory Medicine (423 citations) and Public Health, Environmental and Occupational Health (342 citations). David Wyld has collaborated with scholars based in Australia, United States and New Zealand. Frequent co-authors include Monika Janda, Vanessa L. Beesley, David Goldstein, Rachel Ε. Neale, Helen Gooden, Neil D. Merrett, Dianne L. O’Connell, Ken McFarland, Euan Walpole and Damien Thomson. Their work appears in journals such as Journal of Clinical Oncology, Supportive Care in Cancer, Psycho-Oncology, Neuroendocrinology and International Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.